Nudging Consent and the New Opt Out System to the Processing of Health Data in England

Janos Meszaros,Chih-hsing Ho,Marcelo Corrales Compagnucci

2024-07-28

Abstract:This chapter examines the challenges of the revised opt out system and the secondary use of health data in England. The analysis of this data could be very valuable for science and medical treatment as well as for the discovery of new drugs. For this reason, the UK government established the care.data program in 2013. The aim of the project was to build a central nationwide database for research and policy planning. However, the processing of personal data was planned without proper public engagement. Research has suggested that IT companies, such as in the Google DeepMind deal case, had access to other kinds of sensitive data and failed to comply with data protection law. Since May 2018, the government has launched the national data opt out system with the hope of regaining public trust. Nevertheless, there are no evidence of significant changes in the ND opt out, compared to the previous opt out system. Neither in the use of secondary data, nor in the choices that patients can make. The only notorious difference seems to be in the way that these options are communicated and framed to the patients. Most importantly, according to the new ND opt out, the type 1 opt out option, which is the only choice that truly stops data from being shared outside direct care, will be removed in 2020. According to the Behavioral Law and Economics literature (Nudge Theory), default rules, such as the revised opt out system in England, are very powerful, because people tend to stick to the default choices made readily available to them. The crucial question analyzed in this chapter is whether it is desirable for the UK government to stop promoting the type 1 opt outs, and whether this could be seen as a kind of hard paternalism.

Computers and Society,Artificial Intelligence

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is about the challenges brought by the revised opt - out system in the secondary use of health data in England, UK. Specifically, the paper explores the following points:

1. **The value of secondary use of health data**: The paper points out that these data are of great value for scientific research, medical treatment and the discovery of new drugs. Therefore, in 2013, the UK government launched the "care.data project", aiming to establish a national central database for research and policy planning.

2. **The problem of insufficient public participation**: However, during the implementation of this project, public participation was not carried out fully, resulting in a lack of public trust. Especially in the case of the cooperation between Google DeepMind and the NHS, the IT company was alleged to have accessed other sensitive data and failed to comply with data protection laws.

3. **The new National Data Opt - out (ND opt - out)**: In order to regain public trust, since May 2018, the UK government has launched the "National Data Opt - out system". However, the paper points out that, compared with the old opt - out system, this new system has no significant changes, and there is no obvious improvement in either the secondary use of data or patient choice. The only significant difference lies in how these options are communicated and presented to patients.

4. **The influence of default rules**: According to the "Nudge Theory" in the behavioral law and economics literature, default rules are very powerful because people tend to stick to the default options already provided to them. The paper explores whether such default rules will lead to a kind of "hard paternalism", that is, whether the government should stop promoting type - 1 opt - out options.

In conclusion, this paper mainly focuses on whether the design of the opt - out system in the secondary use of health data by the UK government is reasonable, and whether this design will affect patients' autonomy and data privacy.